Allergy Therapeutics News
Most Popular Allergy Therapeutics Story
Allergy Therapeutics afflicted by FDA's move to halt trials
Shares of Allergy Therapeutics tumbled 22 percent after the FDA froze two late-stage studies of a hayfever vaccine after one of the volunteers in a trial fell ill. The patient reported neurological... Read more...
Latest Headlines
- March 23, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
